PM Edition: Here are the top 10 business articles on LiveNews.co.nz for July 27, 2026 – Full Text
1. More Auckland Residents Choosing Cash for Cars Services
July 26, 2026
Source: Press Release Service
Headline: More Auckland Residents Choosing Cash for Cars Services
Cars4Cash highlights the growing demand for fast and hassle-free vehicle disposal in 2026. The company helps vehicle owners across Auckland and New Zealand sell unwanted, WOF-failed, damaged, scrap, and non-running vehicles with instant cash offers, free removal, and a simple ownership transfer process. By recycling usable vehicle parts, Cars4Cash supports environmentally responsible disposal while providing a convenient alternative to costly repairs and lengthy private sales.
The post More Auckland Residents Choosing Cash for Cars Services first appeared on PR.co.nz.
Original source: https://nz.mil-osi.com/2026/07/26/more-auckland-residents-choosing-cash-for-cars-services/
Back to index · Read original article
2. Breaking the Bed Bug Control Industry Bottleneck: Nobedbugs-HK Redefines Global Bed Bug Eradication Standards with Proprietary Technology
July 25, 2026
Source: Media Outreach
HONG KONG SAR – Media OutReach Newswire – 24 July 2026 – Against the backdrop of surging global mobility and expanding business travel sectors, densely populated urban residential blocks and commercial buildings have sprung up worldwide. The cross-regional spread and rampant breeding of bed bugs have escalated into a transnational public health concern disrupting residents’ daily lives and commercial operations. Plagued by longstanding technical limitations and rampant service irregularities within the pest control sector, Hong Kong’s professional bed bug eradication brand Nobedbugs-HK has emerged as a global industry benchmark through self-developed technologies and over 10,000 verified service cases. Featured extensively in authoritative special reports, the brand delivers a one-stop, long-lasting professional bed bug treatment solution for households and commercial clients worldwide, boasting a 100% eradication success rate powered by its proprietary thermal treatment technology and custom pest control formulations.
Targeting Limitations of Conventional Practices: Nobedbugs-HK Engineers Precision-Driven Bed Bug Remediation Solutions
The pest control industry is marked by uneven entry barriers. Most traditional exterminators rely solely on chemical sprays, which only eliminate surface bed bugs. Eggs and nymphs concealed within wall crevices and furniture remain untouched, failing to resolve infestations at their source and leading to frequent recurrences. This superficial treatment model has triggered a steady stream of consumer complaints and dissatisfaction. Compounding the issue, many pest control firms lack the technical expertise and field experience to address tight spaces or cluttered environments, creating treatment blind spots that compromise eradication efficacy and introduce potential safety hazards during operations.
Contrary to the industry’s prevalent profit-driven, perfunctory service model that overpromises underdelivers, Nobedbugs-HK upholds its founding mission of sharing technical expertise to advance the entire sector. Its team regularly conducts technical seminars and exchange programs for property management, hospitality and pest control practitioners across multiple countries and regions. These sessions elaborate on bed bug breeding triggers, transmission pathways, scientific eradication methodologies and routine prevention protocols. The global pest control industry has long grappled with stagnant technology and outdated operational standards. Nobedbugs-HK’s cross-border knowledge exchange initiatives bridge regional technical gaps, steering the industry away from crude, slipshod treatment protocols toward rigorous, science-led remediation. These global outreach efforts have also equipped the brand with an extensive international perspective and cross-jurisdictional service expertise.
Driven by proprietary technological innovation and a global operational vision, Nobedbugs-HK has built its market footprint and sterling professional reputation through consistent, reliable eradication results. Its technological breakthroughs and contributions to the industry have garnered coverage from leading international media outlets. This authoritative global recognition underscores overseas markets’ high regard for Hong Kong’s pest control innovations and validates the city-developed bed bug treatment framework as a benchmark for global adoption.
Self-Developed Thermal Treatment Technology Boosts Bed Bug Remediation Efficiency in High-Rise Buildings
Bed bug control in high-rise structures remains a longstanding technical challenge plaguing pest control professionals worldwide. Conventional extermination methods are only viable for low-rise or open-plan spaces and prove ineffective against the complex structural layouts of high-rises, enabling persistent, recurring bed bug infestations. Addressing this global technical gap, Nobedbugs-HK independently engineered the world’s exclusive thermal treatment system and custom operating procedures tailored specifically for high-rise complexes, delivering a transformative solution to this decades-long industry pain point.
A radical departure from traditional chemical pesticide applications, this proprietary technology leverages physical high-temperature treatment to penetrate the most concealed structural recesses. It eliminates 95% of all bed bug life stages—adults, nymphs and deeply embedded eggs—to sever their reproductive cycle at the root. Complemented by the brand’s exclusive formulations, the treatment creates a long-lasting residual protective barrier that blocks cross-unit bed bug migration from adjacent premises. Unlike chemical-based extermination, high-temperature thermal treatment leaves zero chemical residues, generates no indoor contamination and poses no harm to human occupants, rendering it ideal for residential complexes, hotels, office towers and shopping malls. It resolves the core challenges of bed bug remediation in high-rise buildings with unmatched precision, with no comparable technology or service available globally to date.
Over 10,000 Cases Inform Standardised Service Protocols
Real-world case outcomes serve as the ultimate metric for gauging technological performance. Many industry players offer no efficacy guarantees and provide virtually non-existent after-sales support, leaving clients burdened with recurring infestations and repeated service fees. To date, Nobedbugs-HK has completed over 10,000 bed bug remediation projects solely within Hong Kong, serving residential properties, five-star hotels, corporate office towers and chain enterprises across diverse urban residential and commercial environments. Backed by its proprietary thermal treatment technology and standardised construction workflows, the brand maintains a flawless 100% permanent eradication track record across all cases, effectively suppressing bed bug resurgence with zero treatment failures. Its proven track record of thousands of successful cases has countered widespread industry malpractice, earning widespread acclaim and positive client testimonials across Hong Kong’s online forums and social media platforms.
Beyond its core treatment technology, mainstream commercial pest control products lack targeted efficacy against bed bugs’ unique nesting and reproductive traits, a key driver of recurring infestations. Generic formulations fail to counter the pests’ elusive hiding instincts and rapid breeding cycles, drastically diminishing treatment outcomes. Drawing on data accumulated from over 10,000 field cases, Nobedbugs-HK independently develops and manufactures custom bed bug control formulations. Iteratively refined for deployment across diverse global environments, these safe, non-toxic and long-lasting products are widely recognised by industry practitioners as the gold standard for bed bug mitigation. The brand delivers bespoke, meticulous bed bug eradication solutions tailored for Hong Kong residents, standing in stark contrast to competing service providers that offer minimal after-sales support.
Industry specialists identify two critical barriers to effective bed bug control: the stringent technical requirements for densely populated premises and the complete elimination of infestations at their source—two persistent flaws that have hindered conventional pest control operations for years. Armed with its one-of-a-kind global thermal treatment technology, in-house proprietary formulations, international operational insights and thousands of successful remediation cases, Nobedbugs-HK comprehensively rectifies the shortcomings of traditional extermination models. Beyond providing permanent relief for household and commercial bed bug infestations, the brand has established a new universal benchmark for the global bed bug control industry.
Hashtag: #NobedbugsHK
The issuer is solely responsible for the content of this announcement.
– Published and distributed with permission of Media-Outreach.com.
Back to index · Read original article
3. HKU Launches First Community Pharmacist-Led Osteoporosis Screening Programme in Hong Kong
July 23, 2026
Source: Media Outreach
COSA Risk Assessment Tool Deployed Across Community Pharmacies to Identify Undiagnosed Patients
(from left) Ms Kuki Ku, a Christian Family Service Centre (CFSC) community pharmacist; Mr. Gary Kong Ching-yue, Programme Director – Primary Health Care Services, CFSC; Professor Cheung Ching-lung, Associate Professor, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, the University of Hong Kong and Ms Shum, a participant of COSA screening service, support more community pharmacies and other primary healthcare platforms establish osteoporosis screening, working collaboratively to build a comprehensive bone health management network rooted in “early identification, timely diagnosis, and prompt treatment.”
Despite being one of the most prevalent bone diseases in Hong Kong, osteoporosis is estimated to go undiagnosed and untreated in up to 80% of those affected, largely because the disease is asymptomatic until a fracture occurs. By embedding screening within the familiar and accessible setting of community pharmacies, this programme represents a significant step forward in closing the gap between disease burden and clinical intervention.
Osteoporosis Can Lead to Fragility Fractures with Mortality Rates Comparable to Major Cancers
Osteoporosis affects approximately 30% of women and 8% of men aged over 50 or above in Hong Kong, causing progressive deterioration of bone density that leaves patients vulnerable to fragility fractures — fractures that occur from low-impact forces such as a minor fall or even a sudden movement. These fractures carry consequences far beyond physical injury.
Research demonstrates that the one-year mortality rate following a hip fracture can exceed that of certain common cancers, including prostate and breast cancer. Local hospital data further indicate that nearly half of all patients who sustain a fragility hip fracture do not survive beyond five years. Despite these grave outcomes, public awareness remains alarmingly low: international studies suggest that fewer than one in ten at-risk individuals proactively seek a bone mineral density assessment.
Community Pharmacies as an integral part of Primary Healthcare with Pharmacists Playing a Key Role
Recognising the urgent need for a scalable, community-based approach to osteoporosis detection, community pharmacies are increasingly recognised as one of the vital platforms for screening and health education. Community pharmacies play a unique position in the primary healthcare ecosystem — they are among the most frequently visited and trusted healthcare touchpoints in daily life, offering not only medication dispensing but also accessible health consultations, disease prevention education, risk assessments, and referrals, serving as a critical component of the primary healthcare ecosystem.
Standardising the COSA Screening Process to Reach High-Risk Individuals in the Community
Since 2026, the Department of Pharmacology and Pharmacy at HKUMed has collaborated with multiple community pharmacies to introduce a standardised osteoporosis risk assessment protocol into the community, enabling specially trained community pharmacists to utilise the COSA tool to screen high-risk individuals. The assessment requires only four data points — sex, age, body weight, and prior fracture history — and can be completed within minutes during a routine pharmacy visit.
Pharmacists trained in the protocol explain results to patients immediately upon completion. Individuals identified as high-risk receive a written referral to a family physician or other healthcare professionals for further evaluation, including Dual-energy X-ray Absorptiometry (DXA) scanning to confirm diagnosis. All participants, regardless of risk classification, receive bone health education, including guidance on calcium and vitamin D intake, balanced diets, appropriate weight-bearing exercise, fall prevention, and other lifestyle modifications. Studies have demonstrated that these non-pharmacological interventions independently reduce fracture incidence, offering bone protection even in the absence of drug therapy.
Promising Early Results: Approximately 60% of High-Risk Individuals Willing to Undergo Assessment
Since the programme’s launch, community pharmacists have proactively approached over 1,000 high-risk individuals — defined as men aged 70 or above, women aged 65 or above, and adults aged 50 or above with at least one additional osteoporosis risk factor — and invited them to complete the COSA assessment. Notably, approximately 60% of those approached agreed to undergo the assessment, demonstrating that community pharmacy-based osteoporosis screening is an effective means of raising public awareness of the disease and encouraging individuals to take an active role in managing their own health. Of those assessed, more than 100 individuals were identified as being at very high risk for osteoporosis and were referred to family physicians for further diagnostic workup. These findings confirm that this service model can effectively reach and identify undiagnosed high-risk individuals hidden within the community, facilitating early detection and timely intervention.
“Osteoporosis is a disease that is too often discovered only after a fracture has already occurred,” said Professor Cheung Ching-lung, Associate Professor, Department of Pharmacology and Pharmacy, HKUMed. “By integrating COSA screening into community pharmacies, we have been able to reach a substantial number of high-risk individuals who had never previously undergone assessment. Establishing routine screening services within community pharmacies not only helps elevate public understanding of bone health but also facilitates the early identification of undiagnoised patients, promoting timely diagnosis and treatment through established referral pathways.”
Proactive Outreach by Community Pharmacies Enhances Screening Accessibility
The Diamond Hill Family Pharmacy, operated by the Christian Family Service Centre (CFSC), is among the participating sites offering osteoporosis screening and health counselling as part of this programme. “Community pharmacies are places people trust and visit regularly. This programme demonstrates precisely how community-based healthcare can extend disease prevention and health education into everyday life. We are delighted to support this clinical model that brings practical osteoporosis screening services into the community so that more high-risk individuals can receive early assessment.” said Mr Gary Kong Ching-yue, Programme Director – Primary Health Care Services, CFSC.
Ms Kuki Ku, a CFSC community pharmacist involved in the programme, highlighted a natural entry point that has proven particularly effective: many older adults visit pharmacies routinely to purchase calcium supplements or vitamin D — products directly associated with bone health. This provides pharmacists with an organic opportunity to initiate a conversation about bone health, introduce the COSA assessment, and deliver personalised guidance on nutrition and exercise to support bone density maintenance. Ms Ku recalled one particularly illustrative case: during a routine COSA screening, she identified an elderly woman as being at high risk for osteoporosis and promptly referred her to a family doctor for further evaluation, including a DXA scan. The scan revealed osteoporosis . She is currently consulting with her doctor on follow-up management to reduce further bone loss.
Ms Shum, a participant of COSA screening service in her eighties living with hypertension, hyperglycaemia, and hypercholesterolaemia, visited the pharmacy to collect a blood glucose meter. At the pharmacist’s invitation, she completed the COSA osteoporosis screening — an encounter she had not anticipated. Her results indicated a high risk for osteoporosis, and she was issued a referral letter alongside personalised advice on fracture-preventive exercise and dietary calcium intake.
Standardised Guidelines and Training Readiness Pave the Way for Expanded Osteoporosis Screening
With Hong Kong’s rapidly ageing population, the number of osteoporosis patients is projected to rise continuously, with hip fracture cases potentially surging several-fold to reach 27,468 cases by 2050. To strengthen community bone health management, the Department of Pharmacology and Pharmacy at HKUMed has developed a comprehensive practice guideline for community-based osteoporosis screening services. These guidelines encompass the latest disease management information, standardised screening protocols, public education materials, and referral mechanisms, and have been officially reviewed by The Osteoporosis Society of Hong Kong (OSHK).
Additionally, the Department has launched an online Continuing Pharmacy Education (CPE) course to provide training for pharmacists, supporting the standardised development of the service. With guidelines, training courses, and referral pathways now established, the community screening service is fully equipped for expansion. This sets the foundation for more community pharmacies to adopt the service and enables future integration into District Health Centres (DHCs) and other primary healthcare platforms, working collaboratively to build a comprehensive bone health management network rooted in “early identification, timely diagnosis, and prompt treatment.”
Hashtag: #香港大學醫學院 #藥理及藥劑學系 #骨質疏鬆症 #張正龍教授 #COSA #社區藥房 #骨質疏鬆症篩查 #ChineseOsteoporosisScreeningAlgorithm #COSA #HKUMed #Osteoporosis #CommuniyPharmacy #DepartmentofPharmacologyandPharmacy #ProfCheungChingLung
The issuer is solely responsible for the content of this announcement.
– Published and distributed with permission of Media-Outreach.com.
Back to index · Read original article
4. Nanyang Optical Co. Pte Ltd (In Liquidation) Announces Tender Sale of Optical Inventory Located in Shenzhen, China
July 23, 2026
Source: Media Outreach
SHENZHEN, CHINA – Media OutReach Newswire – 23 July 2026 – Nanyang Optical Co. Pte Ltd (In Liquidation) is inviting expressions of interest from optical retailers, distributors, wholesalers, exporters, and trade buyers for the acquisition of its inventory through a tender sale process.
The inventory, currently located in Shenzhen, China, presents an opportunity for businesses in the optical industry to acquire a substantial range of products suitable for retail, wholesale, and export markets.
Available inventory includes:
- Optical frames
- Sunglasses
- Optical and related inventory
Interested parties are invited to obtain detailed inventory listings and tender documentation and submit offers in accordance with the tender sale process.
This opportunity may be of interest to companies seeking to expand their product offerings, replenish inventory, or secure eyewear stock for regional and international markets.
For enquiries, inventory listings, and tender documents, please contact:
Robert Khan & Co Pte Ltd
Tel: +65 6333 5668
WhatsApp: +65 8223 0954
WeChatID: RobertKhanCo
Email: tender@robertkhanco.com
Website: robertkhanco.com
https://robertkhanco.com/
https://www.linkedin.com/company/105576231/admin/dashboard/
https://x.com/robertkhan
https://www.facebook.com/robertkhancosg#
Wechat: RobertKhanCo
https://www.instagram.com/rkco_pte_ltd
Hashtag: #RobertKhanCo
The issuer is solely responsible for the content of this announcement.
– Published and distributed with permission of Media-Outreach.com.
Back to index · Read original article